Translational Development Acquisition Corp. (TDAC) P/E Ratio History
Historical price-to-earnings valuation from 2025 to 2025
Loading P/E history...
TDAC Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of May 8, 2026, Translational Development Acquisition Corp. (TDAC) trades at a price-to-earnings ratio of -656.2x, with a stock price of $10.63 and trailing twelve-month earnings per share of $0.28.
The current P/E is 2820% below its 5-year average of 24.1x. Over the past five years, TDAC's P/E has ranged from a low of 19.8x to a high of 28.5x, placing the current valuation at the 0th percentile of its historical range.
Compared to the Financial Services sector median P/E of 13.1x, TDAC trades at a 5092% discount to its sector peers. The sector includes 775 companies with P/E ratios ranging from 0.0x to 195.8x.
Relative to the broader market, TDAC trades at a notable discount to the S&P 500 median P/E of 25.1x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our TDAC DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
TDAC P/E vs Peers
P/E ratio compared to closely matched public peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $16M | 9.7Lowest | - | -4% | |
| $288B | 22.8 | 1.63 | +77%Best | |
| $303B | 23.9 | 2.69 | +53% | |
| $826B | 15.5 | 1.19Best | +22% | |
| $13B | 23.6 | 2.08 | +55% | |
| $4B | 21.4 | - | -19% | |
| $4B | 22.9 | 2.63 | +36% |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
TDAC Historical P/E Data (2025–2025)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2025 Q3 | $10.35 | $0.52 | 19.8x | -18% | |
| FY2025 Q2 | Mon Jun 30 2025 00:00:00 GM | $10.27 | $0.43 | 24.0x | -0% |
| FY2025 Q1 | Mon Mar 31 2025 00:00:00 GM | $10.08 | $0.35 | 28.5x | +18% |
Average P/E for displayed period: 24.1x
See TDAC's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs TDAC Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare TDAC vs BRK-A
Side-by-side business, growth, and profitability comparison vs Berkshire Hathaway Inc..
Start ComparisonTDAC — Frequently Asked Questions
Quick answers to the most common questions about buying TDAC stock.
Is TDAC stock overvalued or undervalued?
TDAC trades at -656.2x P/E, below its 5-year average of 24.1x. At the N/A percentile of historical range, the stock is priced at a discount to its own history.
How does TDAC's valuation compare to peers?
Translational Development Acquisition Corp. P/E of -656.2x compares to sector median of 13.1x. The discount suggests lower growth expectations or higher risk.
What is TDAC's PEG ratio?
TDAC PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 2025-2025.